The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.

Over the past few weeks, the Trump administration has introduced sweeping changes across the federal government that have impacted the federal ...

The US economy faced a dual setback in January, with both retail sales and manufacturing output recording declines.

On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.